Welcome!
IHH Healthcare
Broker's Calls
IHH, Raffles Medical likely to be hit by fall in medical tourists: CGS-CIMB
SINGAPORE (June 12): Given the hit to medical tourism due to measures to curb the spread of Covid-19, hospital operators are likely to be more severely impacted in 2Q, according to CGS-CIMB Research.
June 12, 2020
Covid-19
Healthcare and glove stocks march on as Wuhan virus continues spread, claims higher deaths
Glove manufacturers and healthcare stocks lead the gainers on Tuesday, as the outbreak of the coronavirus spread to 14 countries, including Singapore.
January 28, 2020
Healthcare
Ageing trend supports spending, but earnings of stocks dip on costs
SINGAPORE (20 Dec) : Eight in 10 medical practitioners say Singapore’s healthcare system should focus more on disease prevention as Singaporeans live longer and are more likely to contract a chronic illness at an earlier age. Moreover, nearly half or 49
December 20, 2019
Results
IHH Healthcare reverses out of the red with 3Q earnings of $77.3 mil
SINGAPORE (Nov 29): IHH Healthcare posted earnings of RM236.3 million ($77.3 million) for 3QFY2019 ended September, reversing from losses of RM104.1 million a year ago.
November 29, 2019
Trans-boundary haze
Hazy skies have little impact on healthcare providers, says CGS-CIMB
SINGAPORE (Sept 25): The ongoing haze has little impact on healthcare providers in terms of revenue or share price, but prolonged haze conditions showed an increase in admissions to private hospitals, an analysis by CGS-CIMB Research has found.
September 25, 2019
M&A
IHH Healthcare to acquire private hospital in Malaysia for $336 mil
SINGAPORE (Sept 17): IHH Healthcare is seeking to strengthen its position in Malaysia with the proposed acquisition of entire issued share capital of Prince Court Medical Centre for RM 1.02 billion ($336 million).
September 17, 2019
Broker's Calls
China could give healthcare players a shot in the arm, says CGS-CIMB
SINGAPORE (June 11): CGS-CIMB Research says China could be the “cure” for anaemic local growth among Singapore-listed healthcare providers, with a total healthcare market size that is some 46 times larger.
June 11, 2019
Broker's Calls
IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB
SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performan
May 31, 2019
In print this week
IHH Healthcare to take offerings to 'whole different level' with digitalisation
SINGAPORE (Apr 12): Towards the end of July 2012, at a meeting with bankers and fund managers in the run-up to IHH Healthcare’s IPO, an executive of a financial institution asked what was so special about the healthcare provider. “If we throw a few bi
April 12, 2019
Broker's Calls
Analysts look beyond IHH Healthcare's headline loss to maintain 'buy'
SINGAPORE (Nov 30): Analysts say IHH Healthcare’s 3Q18 headline loss of RM104 million ($34 million) did not come as a surprise, given the 30% q-o-q depreciation of the Turkish lira versus the US dollar.
November 30, 2018